|
| Present status, problems and outlook of safety evaluation for the proprietary Chinese medicine |
| Hits 9209 Download times 2089 Received:April 21, 2017 |
| View Full Text View/Add Comment Download reader |
| DOI
10.11656/j.issn.1673-9043.2017.05.04 |
| Key Words
clinical assessment;safety;Chinese patent medicine;post-marketing |
| Author Name | Affiliation | | ZHENG Wen-ke | Tianjin Branch of the Ministry of Education Virtual Research Center for Evidence-Based Medicine, Tianjin 300193, China |
|
| Abstract
|
| The article objectively discusses the present status of safety evaluation for the proprietary Chinese medicine in China. Traditional Chinese medicines' security issues have been caused extensive concern by society, there are many limitations of proprietary Chinese medicine in safety evaluation, for lack of scientific evidence, the post-marketing safety evaluation work of TCM is urgently needed. At present, the goverment, institutes, pharmaceutical companies of TCM and so on are actively exploring and carrying out related works, and have made gratifying achievements. But there still exist various aspects of related questions, such as the relevant specification, the top-level design, quality control, benefit and so on. There are some more work for further improving the safety evaluation system of proprietary Chinese medicine. |
|
|
|
|
|
